As a token of appreciation to our LEGENDary team, we had a visit from an ice cream truck at our global headquarters in Somerset, NJ. It was the perfect way to cool down and catch up with colleagues on this hot summer day. #WeAreLegend
About us
Legend Biotech is a global, commercial-stage biotechnology company developing and manufacturing novel therapies. We explore and apply innovative technologies to deliver cutting-edge options for patients around the world. Our corporate headquarters is located in Somerset, NJ, and our manufacturing footprint includes facilities in the United States, China and the Belgium.
- Website
-
https://legendbiotech.com/
External link for Legend Biotech
- Industry
- Biotechnology Research
- Company size
- 1,001-5,000 employees
- Headquarters
- Somerset, New Jersey
- Type
- Public Company
- Specialties
- R&D, Cell Therapy, CAR-T, CAR-T Manufacturing, Biotechnology, and Pharmaceuticals
Locations
Employees at Legend Biotech
-
Steve Gavel
Senior Vice President, Cell Therapy Commercial Development
-
Frederik Buysse
-
Kathy Rosseel
HR Director - International HR Manager - Senior Human Resources Business Partner
-
Senthil Arumugam, MBA
Director of IT - Global Business Technology Solutions Group | Head of Application Development | Cloud Analytics Architect | Business Intelligence |…
Updates
-
#LegendNews: Legend Biotech will host a webcast to share 2024 second-quarter financial results on August 9. Register to join the live webcast here: https://lnkd.in/g8gFDUqv #CellTherapy
-
Our LEGENDs in Ghent, Belgium, embody the phrase “one Legend” and often observe special occasions as a team. Recently, they celebrated the summer solstice together. Team building is a favorite pastime at Legend. Would you like to join our growing team? Click here to see our current openings. https://lnkd.in/e-rXFgQq #WeAreLegend
-
#LegendNews: As we continue our pursuit to transform patients’ lives, we are pleased to announce a positive interim analysis from our Phase 3 #MultipleMyeloma study. Read the topline results: https://bit.ly/4cNaxHt #CellTherapy
-
Explore our state-of-the-art CAR-T Cell processing facility at Tech Lane in Ghent, Belgium. As the demand for our #CellTherapy increases, we are scaling up our capabilities and streamlining our manufacturing processes to expand capacity and meet patients’ needs. Learn more about our approach: https://lnkd.in/eNs5VmNJ #Biotech #CART
-
In an interview with Pharmaceutical Executive, our CEO, Ying Huang, discusses the promising potential of CAR-T therapies as they move up the #MultipleMyeloma treatment paradigm. Click here to read the article and learn more about our latest data presented at #ASCO24: https://lnkd.in/eer3kCSx
-
Legend Biotech was featured in Scientific American, where we discussed the success of CAR-T cell therapies in transforming the treatment paradigm for #MultipleMyeloma. Learn how we are racing to treat more patients faster: https://lnkd.in/eC_iEmMc #CellTherapy #CART
CAR-T Cells Approach Cancer’s Front Lines
scientificamerican.com
-
We are excited to share the latest data from our #MultipleMyeloma studies at the European Hematology Association (EHA)’s Congress in Madrid this weekend. Attending the meeting? Click for details on our oral and four poster presentations: https://bit.ly/3R3DeaO #EHA2024 #CellTherapy
-
We are #hiring! Our growing global team aims to transform the #CellTherapy landscape in hematology and oncology. Meet our colleagues in Belgium and hear how their passion for patients is driving our transformational science. Interested in working alongside LEGENDary teams? Find open roles across our offices at https://lnkd.in/e-rXFgQq. #Biotech #JoinOurTeam
-
Our Head of Manufacturing Sciences & Technology (MS&T), Pieter Jacobs, was part of an esteemed panel organized by EP PerMed - the European Partnership for Personalised Medicine that brainstormed ways to expedite the production of personalized medicines. The roundtable focused on the immediate need to attract top talent and support ingenuity that drives advances in technology and manufacturing. Legend Biotech is proud to be leading the development of cell therapy technology in Europe. #EPPerMed #PersonalisedMedicine #CellTherapy #CART
Similar pages
Browse jobs
Stock
LEGN
NASDAQ
20 minutes delay
$55.90
1.91 (3.538%)
- Open
- 54.47
- Low
- 54.27
- High
- 57.82
Data from Refinitiv
See more info on